While Wegovy is the only Semaglutide product specifically approved by the FDA for weight loss (Novo), its counterparts, Ozempic and Rybelsus, are only approved for managing diabetes (FDA U.S
Instead, her biggest challenge was fatigue in the early weeks
Dosing is introduced gradually, with clear education and expectations provided
"Many reported oral effects appear to be secondary to the gastrointestinal side effects of GLP-1 therapy rather than direct oral toxicity," says Chole Tsang, DMD, a dentist at Tend in New York City
Despite the therapeutic success, currently available GLP-1R agonists are suboptimal due to poor patient compliance caused by subcutaneous injections and several side effects such as nausea and vomiting 4,5